Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COPD
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
Hepatitis
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Rheumatoid Arthritis
RSV
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
SCHIZOPHRENIA
June 6, 2023
Identifying and Treating Insomnia in Patients With Schizophrenia
June 6, 2023
Role of Vitamin D Deficiency in Disease Pathogenesis
June 6, 2023
Risk of Hip Fractures in Individuals With Schizophrenia
April 19, 2023
Two Novel Genes That May Heighten Risk for Schizophrenia
April 19, 2023
Exploring Combined Treatment for Motivational Negative Symptoms
April 19, 2023
Schizophrenic Brain Glutamate Levels Compared With General Population
March 19, 2020
Antipsychotics for Pain Management
November 15, 2018
The Role of the Community Pharmacist in Mental Health
August 29, 2018
New Advice on Prescribing for First-Episode Schizophrenia Patients
December 15, 2008
Clinical News Digest
November 19, 2007
Metabolic Effects of Atypical Antipsychotics
Load More
X
August 2024
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image